Open Science is a term that extends beyond just open access publishing to include a wide range of activities from basic biological research to clinical research, that makes it easier for scientists and clinicians to share and access knowledge, resources, tools, and data.
The premise of Open Science is that research will progress faster if data and knowledge are openly shared with proper data safety measures and ethical frameworks and that has been the case during the current global pandemic.
But despite significant progress, Open Science principles and practices still need to be more formally embedded within clinical research institutions and organisations.
This episode was part of a podcast series funded by Pfizer to celebrate 2021 International Open Access Week. The series interviewed experts working within clinical and medical disciplines who shared their perspectives on the impact and benefit of open science for patients and key stakeholders.
Today's podcast's guest is Dr Guy Rouleau, Director at The Neuro, McGill’s Montreal Neurological Institute-Hospital, and the co-Founder of the Tanenbaum Open Science Institute.
In 2020, Dr Rouleau was recognised with Canada’s highest civilian honour, the Order of Canada, for his outstanding contributions as a clinician-scientist and as a leader in health care. He also received the Gairdner award for his work on Open Science.